Oncology Drug Discovery and Targeted Therapies

Oncology drug discovery focuses on identifying molecular targets, signaling pathways, and tumor microenvironment interactions to develop precision cancer therapies. Targeted treatments include kinase inhibitors, monoclonal antibodies, immune checkpoint modulators, and antibody-drug conjugates. Integration of genomics, proteomics, and computational modeling accelerates identification of actionable mutations and patient-specific therapies. Preclinical models and high-throughput screening facilitate selection of potent and selective compounds, while clinical trials evaluate efficacy, safety, and resistance mechanisms. Precision oncology strategies aim to optimize therapeutic response, minimize toxicity, and provide tailored interventions for diverse cancer types.

    Related Conference of Oncology Drug Discovery and Targeted Therapies

    January 22-23, 2026

    26th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    February 25-26, 2026

    16th International Conference on Chemistry Meeting

    Paris, France
    February 26-27, 2026

    29th World Congress on Materials Chemistry

    Paris, France
    June 17-18, 2026

    15th World Congress on Chromatography

    Paris, France
    August 11-12, 2026

    5th World Congress on Plasma Chemistry and Plasma Processing

    Amsterdam, Netherlands
    September 21-22, 2026

    16th International Chemistry Congress

    Barcelona, Spain
    November 26-27, 2026

    6th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Oncology Drug Discovery and Targeted Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in